Aluminum Exposure Induces Time-Dependent Cognitive Decline, Anxiety, and Brain Aluminum Accumulation in Rats
Abstract
BACKGROUND: Aluminum, a nonessential element, can accumulate in the brain and has been implicated in neurodegenerative disorders such as Alzheimer’s disease (AD). Although previous studies have examined aluminum neurotoxicity, many focus on a single time point, limiting insight into how aluminum accumulates over time. This study addresses that gap by investigating time-dependent aluminum accumulation and associated neurobehavioral changes in rats at 14, 28, and 42 days.
METHODS: Male Wistar rats were administered 200 mg/kg/day aluminum chloride (AlCl3) via oral gavage for 14 (acute), 28 (subacute), and 42 (subchronic) days. Cognitive and anxiety-like behaviors were assessed using the 2-novel object recognition (2NOR) test, spontaneous alternation Y-maze, and open field test (OFT). Brain aluminum levels were quantified using inductively coupled plasma mass spectrometry (ICP-MS).
RESULTS: There were impairments in spatial and non-spatial memory and increased anxiety-like behavior across all exposure durations (p<0.05). Non-spatial memory performance decreased by 50.5%, 37.7%, and 56.2% on day-14, -28, and -42, respectively. Spatial memory significantly declined by 34.3% and 43.2% on day-14 and -42, respectively, while the 20.0% decrease at day-28 was not statistically significant. Anxiety-like behavior increased, with center zone entries reduced by 37.6%, 64.9%, and 62.9% across the same time points. Brain aluminum concentrations were significantly elevated in all aluminum-exposed groups compared to controls, with increases of 2,622.6%, 314.7%, and 969.3% on day-14, -28, and -42, respectively (p<0.05). The increase was not strictly proportional to exposure duration, suggesting possible homeostatic regulation. Weight and liver assessments confirmed the subtoxic nature of the exposure.
CONCLUSION: Exposure to aluminum for 42 days induces behavioral deficits and increases brain aluminum levels, which may support its potential relevance as a model to study aluminum-induced neurotoxicity.
KEYWORDS: aluminum exposure, cognitive function, anxiety, temporal progression, neurobehavioral changes
References
Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev. 2007; 10(Supl 1): 1-269, CrossRef.
Lukiw WJ, Kruck TPA, Percy ME, Pogue AI, Alexandrov PN, Walsh WJ, et al. Aluminum in neurological disease - a 36 year multicenter study. J Alzheimers Dis Parkinsonism. 2019; 8(6): 457, CrossRef.
Hiller J, Göen T, Seibold-Wulf N, Meyer S, Drexler H. Effect of an aluminum foil-processed diet on internal human aluminum burden. Environment International. 2023; 177: 108000, CrossRef.
Palacio LC, Durango-Giraldo G, Zapata-Hernandez C, Santa-González GA, Uribe D, Saiz J, et al. Characterization of airborne particulate matter and its toxic and proarrhythmic effects: A case study in Aburrá Valley, Colombia. Environ Pollut. 2023; 336: 122475, CrossRef.
Yokel RA, Florence RL. Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. Toxicology. 2006; 227(1-2): 86-93, CrossRef.
Jadhav R, Kulkarni YA. Effects of baicalein with memantine on aluminium chloride-induced neurotoxicity in Wistar rats. Front Pharmacol. 2023; 14: 1034620, CrossRef.
Anyanwu GE, Nwachukwu IJ, Oria SR, Obasi KK, Ekwueme EP, Nto JN, et al. Fisetin attenuates AlCl(3)-induced neurodegeneration by modulating oxidative stress and inflammatory cytokine release in adult albino wistar rats. Toxicol Rep. 2024; 13: 101812, CrossRef.
Hao W, Zhu X, Liu Z, Song Y, Wu S, Lu X, et al. Aluminum exposure induces central nervous system impairment via activating NLRP3-medicated pyroptosis pathway. Ecotoxicol Environ Saf. 2023; 264: 115401, CrossRef.
Elariny HA, Kabel AM, Selim H, Helal AI, Abdelrahman D, Borg HM, et al. Repositioning canagliflozin for mitigation of aluminium chloride- induced Alzheimer's disease: Involvement of TXNIP/NLRP3 inflammasome axis, mitochondrial dysfunction, and SIRT1/HMGB1 signalling. Medicina. 2024; 60(11): 1805, CrossRef.
Anna M, Andi W. The search for biomarkers in Alzheimer's disease. Indones Biomed J. 2010; 2(1): 4-25, CrossRef.
Mantzavinos V, Alexiou A. Biomarkers for Alzheimer's disease diagnosis. Curr Alzheimer Res. 2017; 14(11): 1149-54, CrossRef.
OECD [Internet]. Test No. 407: Repeated dose 28-day oral toxicity study in rodents. OECD Guidelines for the Testing of Chemicals, Section 4 [updated 2025 June 25; cited 2025 July 3]. Available from: https://www.oecd.org/.
OECD [Internet]. Test No. 408: Repeated dose 90-day oral toxicity study in rodents. OECD Guidelines for the Testing of Chemicals, Section 4 [updated 2025 June 25; cited 2025 July 3]. Available from: https://www.oecd.org/.
OECD [Internet]. Test No. 425: Acute oral toxicity: Up-and-down procedure. OECD Guidelines for the Testing of Chemicals, Section 4 [updated 2022 June 30; cited 2025 July 3]. Available from: https://www.oecd.org/.
Mohapatra D, Kanungo S, Pradhan SP, Jena S, Prusty SK, Sahu PK. Captopril is more effective than perindopril against aluminium chloride induced amyloidogenesis and AD like pathology. Heliyon. 2022; 8(2): e08935, CrossRef.
Charan J, Kantharia ND. How to calculate sample size in animal studies?. J Pharmacol Pharmacother. 2013; 4(4): 303-6, CrossRef.
Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012; 13(2): 93-110, CrossRef.
Rosyidah C, Arozal W, Lee H, Tjandrawinata R, Septiana W. N-acetylcysteine prevents sleep deprivation-induced memory deficit in juvenile rats through the suppression of BDNF, cortisol, acetylcholine levels, and inflammatory cytokines expressions. Indones Biomed J. 2025; 17(2): 143-53, CrossRef.
Vukovic R, Kumburovic I, Joksimovic Jovic J, Jovicic N, Katanić Stanković J, Mihailovic V, et al. N-acetylcysteine protects against the anxiogenic response to cisplatin in rats. Biomolecules. 2019; 9(12): 892, CrossRef.
Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, et al. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem. 2002; 277(47): 44670-6, CrossRef.
Nakamura N, Flasbeck V, Maingret N, Kitsukawa T, Sauvage M. Proximodistal segregation of nonspatial information in CA3: Preferential recruitment of a proximal CA3-Distal CA1 network in nonspatial recognition memory. J Neurosci. 2013; 33(28): 11506-14, CrossRef.
Donoghue T, Cao R, Han CZ, Holman CM, Brandmeir NJ, Wang S, et al. Single neurons in the human medial temporal lobe flexibly shift representations across spatial and memory tasks. Hippocampus. 2023; 33(5): 600-15, CrossRef.
Yolanda S, Redjeki S, Andraini T, Santoso DIS, Ibrahim N, Mailani R. Combination of aerobic exercise and continuous environmental enrichment improves adult male rats' spatial memory: Study on hippocampal insulin like growth factor 1 (IGF-1) and fibroblast growth factor 2 (FGF-2) expression. Indones Biomed J. 2019; 11(2): 210-6, CrossRef.
Yellamma K, Saraswathamma S, Kumari BN. Cholinergic system under aluminium toxicity in rat brain. Toxicol Int. 2010; 17(2): 106-12, CrossRef.
Wang L. Entry and deposit of aluminum in the brain. In: Niu Q, editor. Neurotoxicity of Aluminum. Advances in Experimental Medicine and Biology. Singapore: Springer; 2018. p.39-51, CrossRef.
Shalaby AM, Alnasser SM, Ahmed Khairy D, Alabiad MA, Alorini M, Jaber FA, et al. The neuroprotective effect of ginsenoside Rb1 on the cerebral cortex changes induced by aluminium chloride in a mouse model of Alzheimer's disease: A histological, immunohistochemical, and biochemical study. J Chem Neuroanat. 2023; 129: 102248, CrossRef.
Gonzalez-Rodriguez M, Villar-Conde S, Astillero-Lopez V, Villanueva-Anguita P, Ubeda-Banon I, Flores-Cuadrado A, et al. Human amygdala involvement in Alzheimer's disease revealed by stereological and dia-PASEF analysis. Brain Pathol. 2023; 33(5): e13180, CrossRef.
Grochowski C, Blicharska E, Bogucki J, Proch J, Mierzwińska A, Baj J, et al. Increased aluminum content in certain brain structures is correlated with higher silicon concentration in alcoholic use disorder. Molecules. 2019; 24(9): 1721, CrossRef.
Yang L, Chen L, Li W, Zhang Y, Yang G, Huang B, et al. METTL3-mediated m6A RNA methylation was involved in aluminum-induced neurotoxicity. Ecotoxicol Environ Saf. 2024; 270: 115878, CrossRef.
Yokel RA, Rhineheimer SS, Sharma P, Elmore D, McNamara PJ. Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure. Toxicol Sci. 2001; 64(1): 77-82, CrossRef.
Díaz-Castro B, Robel S, Mishra A. Astrocyte endfeet in brain function and pathology: Open Questions. Annu Rev Neurosci. 2023; 46: 101-21, CrossRef.
Fairley LH, Lai KO, Wong JH, Chong WJ, Vincent AS, D'Agostino G, et al. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease. Proc Natl Acad Sci USA. 2023; 120(8): e2209177120, CrossRef.
Mold MJ, O'Farrell A, Morris B, Exley C. Aluminum and tau in neurofibrillary tangles in familial Alzheimer's disease. J Alzheimers Dis Rep. 2021; 5(1): 283-94, CrossRef.
Besser LM, Gill DP, Monsell SE, Brenowitz W, Meranus DH, Kukull W, et al. Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2014; 28(1): 36-43, CrossRef.
Joly-Amado A, Serraneau KS, Brownlow M, Marín de Evsikova C, Speakman JR, Gordon MN, et al. Metabolic changes over the course of aging in a mouse model of tau deposition. Neurobiol Aging. 2016; 44: 62-73, CrossRef.
Sergi G, De Rui M, Coin A, Inelmen EM, Manzato E. Weight loss and Alzheimer's disease: Temporal and aetiologic connections. Proc Nutr Soc. 2013; 72(1): 160-5, CrossRef.
Minaglia C, Giannotti C, Boccardi V, Mecocci P, Serafini G, Odetti P, et al. Cachexia and advanced dementia. J Cachexia Sarcopenia Muscle. 2019; 10(2): 263-77, CrossRef.
Ali S, Prasad R, Mahmood A, Routray I, Shinkafi T, Sahin K, et al. Eugenol-rich fraction of Syzygium aromaticum (Clove) reverses biochemical and histopathological changes in liver cirrhosis and inhibits hepatic cell proliferation. J Cancer Prev. 2014; 19(4): 288-300, CrossRef.
Zhang Y, Liu Z, Liu R, Wang J, Zheng M, Li Q, et al. Alteration of hepatic gene expression along with the inherited phenotype of acquired fatty liver in chicken. Genes (Basel). 2018; 9(4): 199, CrossRef.
Rasheed N, Hussain HK, Rehman Z, Sabir A, Ashraf W, Ahmad T, et al. Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged mice. Exp Gerontol. 2025; 199: 112659, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i5.3746
Copyright (c) 2025 The Prodia Education and Research Institute

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute